News & Articles
New range of SARS-CoV-2 Spike protein products
Could this easy-to-use system solve your flow cytometry woes?
Flow cytometry expert Kamala Tyagarajan discusses common challenges, offers simple solutions, and shares top tips for experimental success
The power of microfluidics for dynamic time-lapse experiments: On demand webinar
Find out how scientists are subjecting bacteria to rapid oscillatory osmotic shocks to study the biomechanical basis of cell growth and division
Lumit™ Immunoassays: An easier, faster method for analyte detection
Join us on Wednesday, July 1, to learn about the Lumit™ immunoassay technology and how it can simplify your workflow and yield results faster
Discover how Analytical Quality by Design workflows have become increasingly relevant in the pharmaceutical industry
Join us on Tuesday, June 30, to find out how automated AQbD modeling can be used as a strategic approach across analytical operations of a large pharmaceutical company
Gas hydrates: A new hope for sustainable energy
Join us on Wednesday, July 1, to learn about the promising new applications of gas hydrates for sustainable energy and separative technologies
Establishing the etiology and pathogenesis of viral disease with RNAscope
Don’t miss this on-demand webinar exploring how RNAscope technology can be used to detect viral infection and pathogenesis
How PerkinElmer is helping to combat COVID-19
It's comprehensive SARS-COV-2 offerings span RT-PCR, high throughput RNA extraction, automation, ELISA and lateral flow based serology testing.
Analytik Jena celebrates 30th anniversary
30 stories from customers, partners and employees celebrate the past and look ahead to joint success in the future
Imperial to begin first human trials of new COVID-19 vaccine
Clinical researchers are this week set to begin human trials of a new coronavirus vaccine developed by researchers at Imperial College London
Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
The production agreement is part of AstraZeneca’s recently announced in-licensed programme with the University of Oxford
Adjuvants to enhance cellular immune response to vaccines
Increase the effectiveness of human vaccines against infectious diseases such as COVID-19
BIA Separations introduces PrimaS multi-mode ligand bioprocessing technology to facilitate development of advanced therapeutics
Novel platform initially focussed on high-resolution industrial scale processing of therapeutic mRNA
Blue-Ray Biotech announces upgrade of TurboCycler 2 PCR thermal cycler
The new version is more suited for CRISPR assays and NGS applications
Agilent announces new mass spectrometry products at ASMS 2020 Reboot
Mass spec systems address needs of the pharma, biopharma, food, environmental, and life science markets
Harvard researcher tackles the big question in cancer research: Drug resistance
Dr. Fang Xie shares insights from his research into prostate cancer and offers hope of overcoming the growing problem of chemotherapy resistance to improve patient outcomes
CAR-T cells as a model for clinical development and commercialization
Join this expert webinar to discover the complexities and challenges for wide patient access to new chimeric antigen receptor T (CAR-T) cell therapies
Are point-of-use filters really necessary for nuclease removal?
Undetectable levels of DNase and RNase in purified water
Promega announces CE marking for OncoMate MSI Dx Analysis System
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s COVID-19 vaccine
Company exploring further additional global capacity to provide broad and equitable access